City Therapeutics Inc.
CTY | NASDAQ
$21.08
+$0.37 (+1.79%)
Nov 2, 2026, 11:48 AM ET · Market open
Fiscal Year Period Ending | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 | FY 2015 Dec 31, 2015 | FY 2014 Dec 31, 2014 |
|---|---|---|---|---|---|---|
PE Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PEG Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
P/FCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
P/OCF Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
OCF/S Ratio | 40.85 | 44.64 | 28.48 | 29.76 | 28.90 | 31.69 |
Debt / Equity Ratio | 0.59 | 0.60 | 0.78 | 0.84 | 0.81 | 0.80 |
Quick Ratio | 0.73 | 0.81 | 0.81 | 0.61 | 0.66 | 0.82 |
Current Ratio | 0.73 | 0.81 | 0.81 | 0.61 | 0.66 | 0.82 |
Asset Turnover | 0.39 | 0.41 | 0.41 | 0.42 | 0.42 | 0.39 |
Interest Coverage | n/a | 5.94 | 4.97 | 4.86 | 4.78 | 4.55 |
Return on Equity | 18.06% | 16.87% | 17.75% | 12.48% | 12.06% | 10.56% |
Return on Assets | 8.70% | 8.09% | 7.94% | 5.13% | 5% | 4.32% |
Return on Invested Capital | 11.42% | 11.20% | 11.45% | 7.57% | 7.26% | 6.27% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | 87.58% | 76.58% | 60.35% | 119.82% | 125.70% | 144.33% |
FCF Payout Ratio | 71.08% | 46.75% | 92.59% | 94.82% | 102.04% | 86.69% |
Gross Profit Margin | 70.11% | 67.42% | 66.30% | 67.07% | 67.96% | 67.42% |
Net Profit Margin | 22.40% | 19.60% | 19.38% | 12.18% | 11.98% | 10.98% |
Pretax Profit Margin | 30.26% | 25.42% | 20.95% | 19.79% | 19.33% | 18.21% |
Operating Profit Margin | 35.36% | 31.32% | 27.05% | 26.06% | 25.21% | 23.90% |
FCF Margin | 27.91% | 32.39% | 12.95% | 15.63% | 14.99% | 18.51% |
EBITDA Margin | 46.98% | 47.62% | 44.88% | 44% | 45.12% | 45.70% |
Add to Watchlist
Select watchlists to add or remove CTY